Methods and materials for reducing amyloid beta levels within a mammal
AssigneeThe Research Foundation for The State University of New York
InventorsGeorge B. Stefano, Richard M. Kream, Kirk J. Mantione
Life of this patent
Estimating the term…
Abstract
This document provides methods and materials for reducing amyloid beta levels within a mammal (e.g. a mammal having Alzheimer's disease). For example, this document provides methods for using compositions containing a potato polysaccharide preparation to reduce one or more symptoms of Alzheimer's disease. In some cases, a composition containing a potato polysaccharide preparation provided herein can be used to increase binding, sequestration, and/or degradation of CNS-derived amyloid beta polypeptides, thereby inhibiting the formation of neurofibrillary plaques.
Claims17
A method for reducing a symptom of Alzheimer's disease within a mammal having Alzheimer's disease, wherein said method comprises administering to said mammal a composition comprising a potato polysaccharide preparation obtained from raw potatoes, wherein the level of amyloid beta within said mammal is reduced.
(canceled)
Dependencies are inferred from the claim text.